Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 31 MARCH 2026

Le CEPMB lance une consultation concernant le projet de directives relatives à la pratique pour ses audiences

Smart & Biggar
Explore more from Smart & Biggar

pour déterminer si un titulaire de droits a omis de soumettre les renseignements exigés conformément à la Loi sur les brevets et au Règlementsur les médicaments brevetés.

CanadaTechnology
Chen Li
Chen Li
Author LinkedIn connections

Le Conseil d’examen du prix des médicaments brevetés (le « CEPMB ») tient des audiences publiques dans deux types d’instances :

  • pour déterminer si le prix d’un médicament est excessif;
  • pour déterminer si un titulaire de droits a omis de soumettre les renseignements exigés conformément à la Loi sur les brevets et au Règlementsur les médicaments brevetés.

Le 5 mars 2026, le CEPMB a publié un projet de sept directives relatives à la pratique visant à offrir des précisions quant aux questions procédurales associées à ces audiences. Le projet de directives relatives à la pratique, résumé ci-après, vise un alignement sur les approches et technologies modernes tout en favorisant l’efficacité, l’uniformité et l’équité procédurale.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

New AI Safety Standard Relevant To Canadian School Boards

A major U.S. vendor agreement has established a rigorous new AI safety standard for educational technology, prohibiting the use of student data for AI training and enforcing strict data minimization. While the standard does not directly bind vendors in Canada, Canadian school boards can leverage this precedent to demand equivalent contractual protections and strengthen their own AI governance frameworks.
CanadaTechnology
Borden Ladner Gervais LLP
Borden Ladner Gervais LLP
Article

Health Canada Updates Policies On Foreign Regulatory Actions, Summary Reporting, Compliance & Enforcement And Requests For New Data

Health Canada issued revised guidance on notifying Health Canada of foreign actions, effective October 1, 2026. The revised guidance clarifies the requirements to notify Health Canada of certain foreign regulatory actions specified in subsection C.01.050(2) of the Food and Drug Regulations in the specified foreign jurisdictions, which involve a serious risk of injury to human health and are relevant to the safety of the drug.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar
Article

Health Canada Obtains Permanent Injunction To Prevent Illegal Sale Of Injectable Peptides By Canlab Research

Health Canada has secured a permanent injunction against Canlab Research, a Quebec-based online retailer, preventing the company from manufacturing, distributing, or selling unauthorized injectable peptides in Canada. This enforcement action follows years of regulatory warnings and provisional court orders aimed at stopping the illegal sale of peptide drugs promoted with unproven health claims for anti-aging, weight loss, and athletic performance.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar
Article

A KTEP Ahead: Canada's New Mechanism For Advanced Examination Of Patent Applications

For a Canadian patent application to be examined, an applicant must file a request for examination with the Canadian Intellectual Property Office (CIPO). In most cases, the order in which applications are examined is based on the order that the requests for examination are received. An applicant may be able to accelerate examination of their patent application through several existing mechanisms, including advancing examination via special order, accelerating examination of applications related to green technology, and the Patent Prosecution Highway (PPH).
CanadaIntellectual Property
Smart & Biggar
Smart & Biggar